D
Zevra Therapeutics, Inc. ZVRA
$8.31 $0.374.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -129.13% -339.38% -301.09% -29.72% -72.00%
Total Depreciation and Amortization 535.09% 965.13% 364.68% 159.81% 6.57%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 541.72% 236.58% 129.43% -69.86% -25.17%
Change in Net Operating Assets -212.87% -136.68% 35.37% -113.39% 1,549.01%
Cash from Operations -107.74% -218.57% -135.46% -137.68% -79.17%
Capital Expenditure -- 72.09% -114.04% -151.89% -218.28%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -115.76% -115.76%
Divestitures -- -- -- -- --
Other Investing Activities -266.54% 187.72% -31.93% 225.93% 159.05%
Cash from Investing -27.44% 78.23% -215.08% 129.66% 52.64%
Total Debt Issued 37.51% 59.03% 538.18% 14.03% 210.43%
Total Debt Repaid -138.29% -246.78% -230.58% 66.39% -1,269.14%
Issuance of Common Stock 963.54% 22,091.74% 2,766.79% 2,227.47% 1,851.85%
Repurchase of Common Stock -- 100.00% 100.00% 100.00% 27.02%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -3,175.00% -3,175.00% -- --
Cash from Financing 188.46% 272.00% 1,479.80% 258.13% 240.80%
Foreign Exchange rate Adjustments 931.82% 213.79% 52,000.00% -124.54% -78.43%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 58.67% 140.20% -154.52% 104.44% 52.18%
Weiss Ratings